The global distraction osteogenesis devices market size was USD XX Bn in 2022 and is likely to reach USD XX Bn by 2031, expanding at a CAGR of XX% during 2023–2031. Increasing prevalence of pediatric bone defects and genetic disorders is likely to boost the market.
Genetic disorders such as cleft defects are becoming highly prevalent, which is anticipated to propel the demand for distraction osteogenesis (DO) procedures. Some healthcare professionals and scientists believe that the prevalence of pediatric bone deformity is attributed to the recent growth in teenage pregnancies and the lack of proper prenatal care for many women during pregnancy.
- As per the Centers for Disease Control and Prevention (CDC) updated in January 2023, in the US, around 1 in every 1600 babies are born with both cleft lip and cleft palate, and around 1 in every 1700 babies are born with cleft palate, and around 1 in every 2,800 babies are born with cleft lip without palate. Growing cases of the cleft is propelling the demand for distraction osteogenesis devices.
Distraction osteogenesis (DO) technique is used to correct skeletal deformities and bone reconstructive surgeries. It is commonly used to correct maxillary hypoplasia, which refers to bone underdevelopment in the upper jaw. DO devices enable stable and predictable results in patients with cleft lip and palate. These devices aid in vertical alveolus augmentation and speedy orthodontic tooth movement, for those who have cleft disorders. The growing awareness about these treatments and increasing advances in healthcare technology and devices are further accelerating the growth of the market.
The distraction osteogenesis process involves cutting the bone surgically and gradually separating the cut ends to promote the growth of new bone in the gap. This technique is commonly used in orthopedic and maxillofacial surgeries, to correct bone deformities or recorrect bone defects caused due to injuries or congenital conditions.
The market report finds that the COVID-19 pandemic affected the distraction osteogenesis devices market. Healthcare establishments focused on curing COVID-19 patients, resulting in the postponement of non-essential treatments. Several governments across the world imposed strict lockdown regulations during the pandemic, which affected the market. Imports and exports of distraction osteogenesis devices were halted during the pandemic, which contributed to the slow growth of the market.
Distraction Osteogenesis Devices Market Dynamics
Major Drivers
Increasing prevalence of pediatric bone defects is expected to boost the distraction osteogenesis devices market. Bone defects are caused by various factors, such as acute injury, tumor, trauma, or infection. Bone defects occur due to surgical treatment performed to eliminate bone tumors, bone infections, or non-union. Bone defect treatment is done by using internal and external fixation, with the aid of distraction osteogenesis techniques and devices. This factor is expected to boost the market during the forecast period.
- According to the National Institutes of Health (NIH), with above 5.5 million fractures and nearly 1 million bone repair surgeries per year, bone graft plays a substantial role in assisting fracture repair. In the US alone, surgeons perform a projected 500k to 600k bone grafting procedures every year.
Existing Restraints
High cost of distraction osteogenesis treatment and the increasing requirement of surgical procedures for the removal of internal distractors are expected to hamper the distraction osteogenesis devices market. Distraction osteogenesis signifies a prolonged therapy, typically a long-time therapy of at least 3 months, requiring multiple clinical visits and close postoperative follow-ups. Such expenses, surgical procedures, and repetitive visits for therapy impede the market growth.
Emerging Opportunities
Increasing product approvals and launches by key market players is expected to create lucrative opportunities in the market. Manufacturers in the healthcare industry are developing innovative medical devices to meet the needs of patients with bone disorders, which is creating growth potential in the distraction osteogenesis devices market. For instance,
- In May 2022, Acumed LLC, a medical device manufacturer based in Hillsboro, launched the Ulna Nail 2 System. It is created to treat simple, short oblique fractures, transverse, and osteotomies of the ulna. This system is designed to deliver a minimally invasive intramedullary approach to reduce irritation to soft tissue and preserve the osseous blood supply.
Scope of Distraction Osteogenesis Devices Market Report
The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Distraction Osteogenesis Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Device Type (Alveolar Distraction Devices, Mandibular Distraction Devices, Cranial Distraction Devices, Palatal Distraction Devices, Small Bone Distraction Devices, and Others), Product (Internal Distractors and External Distractors), and End-user (Hospitals, Clinics, Research Institutes, Oral & Maxillofacial Surgery Centers, Orthopedics Clinics, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Acumed LLC; JEIL MEDICAL CORPORATION; Johnson & Johnson Services, Inc.; NuVasive, Inc.; KLS Martin Group; Ningbo Cibei Medical Instrument Co., Ltd; Ortho Max Mfg. Co. Pvt. Ltd.; Ortho-Care, LLC; Stryker; Ti-TaMED (Pty Ltd); and Zimmer Biomet
|
Distraction Osteogenesis Devices Market Segment Insights
Device Type Segment Analysis
Based on device type, the distraction osteogenesis devices market is divided into alveolar distraction devices, mandibular distraction devices, cranial distraction devices, palatal distraction devices, small bone distraction devices, and others. The alveolar distraction devices segment is anticipated to expand at a rapid pace during the forecast period, due to the increasing treatments for augmentation of bone and soft tissue.
Alveolar distraction osteogenesis is identified as a biological progression that involves balanced traction between vascularized bone segments to allow the growth of new bone. An osteotomy is usually performed, followed by an osteodistraction device, to manage the separation process.
The mandibular distraction devices segment is anticipated to hold a key share of the market in the coming years, as it is effectively used for elongating the jaw, increasing the pharyngeal airway, and improving the breathing of patients, who suffer from respiratory distress.
Mandibular distraction osteogenesis refers to a surgical technique, where a bone is cut and gradually the two ends are mechanically separated to generate bone between the osteotomy or cut. Some common syndromes associated with mandibular hypoplasia include Pierre robin sequence, Nager syndrome, Hemifacial microsomia, Stickler syndrome, Treacher Collins syndrome, and others.
Product Segment Analysis
On the basis of product, the global market is segregated into internal distractors and external distractors. The internal distractors segment is projected to expand at a considerable CAGR during the forecast period, as it reduces discomfort and the risk of pin tract infection. Internal distractors are used to create a space between the bones. Internal distractors provide an approximate vector of enlargement and an accurate rate of enlargement, due to the direct contact of the device with the bone segment.
The external distractors segment is anticipated to account for a major market share in the coming years, as they permit long distraction length. External distractors are placed externally on the body and are used to slowly separate the bone for the formation of new bone in the space. Polyaxial and monoaxial are two types of external distractors.
- On March 21, 2023, aap Implantate AG, an operating medical device company in Berlin, Germany, announced that its new system LOQTEQ VA Elbow 2.7/3.5 has cleared the US Food and Drug Administration. This system allows flexible treatment of fractures of the distal humerus and olecranon, significant to elbow function and stability.
End-user Segment Analysis
In terms of end-user, the market is segmented into hospitals, clinics, research institutes, oral & maxillofacial surgery centers, orthopedics clinics, and others. The hospitals segment is projected to expand at a rapid growth rate during the forecast period, due to the availability of advanced technology and equipment for the treatment of osteogenesis.
Several treatments are available in hospitals to cure bone defects with the use of distraction osteogenesis devices. These devices are commonly used to correct deformities such as scoliosis and lengthen shortened bones in hospitals.
Regional Analysis
In terms of region, the global distraction osteogenesis devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, due to the rising number of procedures for the treatment of facial abnormalities, especially in the US. Rising number of healthcare facilities that offer the required care for facial defects in the region is anticipated to boost the market.
- According to the Children’s National Hospital, in the US, around 600k individuals have been diagnosed with a craniofacial condition. Each year, hundreds of patients are being treated by the Children’s National Hospital for this condition.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, as key players in the region are focused on setting up businesses to expand their customer base and geographical presence. Growing initiatives by several organizations for offering surgical treatment and care for facial deformities is expected to fuel the market in the region.
Segments
The global distraction osteogenesis devices market has been segmented on the basis of
Device Type
- Alveolar Distraction Devices
- Mandibular Distraction Devices
- Cranial Distraction Devices
- Palatal Distraction Devices
- Small Bone Distraction Devices
- Others
Product
- Internal Distractors
- External Distractors
End-user
- Hospitals
- Clinics
- Research Institutes
- Oral & Maxillofacial Surgery Centers
- Orthopedics Clinics
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Acumed LLC
- JEIL MEDICAL CORPORATION
- Johnson & Johnson Services, Inc.
- NuVasive, Inc.
- KLS Martin Group
- Ningbo Cibei Medical Instrument Co., Ltd
- Ortho Max Mfg. Co. Pvt. Ltd.
- Ortho-Care, LLC
- Stryker
- Ti-TaMED (Pty Ltd)
- Zimmer Biomet
Competitive Landscape
Key players competing in the global distraction osteogenesis devices market are Acumed LLC; JEIL MEDICAL CORPORATION; Johnson & Johnson Services, Inc.; NuVasive, Inc.; KLS Martin Group; Ningbo Cibei Medical Instrument Co., Ltd; Ortho Max Mfg. Co. Pvt. Ltd.; Ortho-Care, LLC; Stryker; Ti-TaMED (Pty Ltd); and Zimmer Biomet.
These market participants are engaging in organic and inorganic strategies, including mergers, acquisitions, collaboration, partnerships, product launches, and production expansion to expand their consumer base globally.
- In March 2023, NuVasive, Inc., announced the approval of 510(K) clearances from the US Food and Drug Administration (FDA) for the use of precise all-internal limb lengthening solutions to include pediatric patients. The extended clearance expands the clinical benefits of precision to a wide range of patients.
Request For Customization
Enquiry Before Buying
Speak With Analyst
